Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests



U.K. Trade Balance Non-EU (SA) (Oct)A:--
F: --
P: --
U.K. Trade Balance (Oct)A:--
F: --
P: --
U.K. Services Index MoMA:--
F: --
P: --
U.K. Construction Output MoM (SA) (Oct)A:--
F: --
P: --
U.K. Industrial Output YoY (Oct)A:--
F: --
P: --
U.K. Trade Balance (SA) (Oct)A:--
F: --
P: --
U.K. Trade Balance EU (SA) (Oct)A:--
F: --
P: --
U.K. Manufacturing Output YoY (Oct)A:--
F: --
P: --
U.K. GDP MoM (Oct)A:--
F: --
P: --
U.K. GDP YoY (SA) (Oct)A:--
F: --
P: --
U.K. Industrial Output MoM (Oct)A:--
F: --
P: --
U.K. Construction Output YoY (Oct)A:--
F: --
P: --
France HICP Final MoM (Nov)A:--
F: --
P: --
China, Mainland Outstanding Loans Growth YoY (Nov)A:--
F: --
P: --
China, Mainland M2 Money Supply YoY (Nov)A:--
F: --
P: --
China, Mainland M0 Money Supply YoY (Nov)A:--
F: --
P: --
China, Mainland M1 Money Supply YoY (Nov)A:--
F: --
P: --
India CPI YoY (Nov)A:--
F: --
P: --
India Deposit Gowth YoYA:--
F: --
P: --
Brazil Services Growth YoY (Oct)A:--
F: --
P: --
Mexico Industrial Output YoY (Oct)A:--
F: --
P: --
Russia Trade Balance (Oct)A:--
F: --
P: --
Philadelphia Fed President Henry Paulson delivers a speech
Canada Building Permits MoM (SA) (Oct)A:--
F: --
P: --
Canada Wholesale Sales YoY (Oct)A:--
F: --
P: --
Canada Wholesale Inventory MoM (Oct)A:--
F: --
P: --
Canada Wholesale Inventory YoY (Oct)A:--
F: --
P: --
Canada Wholesale Sales MoM (SA) (Oct)A:--
F: --
P: --
Germany Current Account (Not SA) (Oct)A:--
F: --
P: --
U.S. Weekly Total Rig CountA:--
F: --
P: --
U.S. Weekly Total Oil Rig CountA:--
F: --
P: --
Japan Tankan Large Non-Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Small Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Large Non-Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Large Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Small Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Large Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Large-Enterprise Capital Expenditure YoY (Q4)--
F: --
P: --
U.K. Rightmove House Price Index YoY (Dec)--
F: --
P: --
China, Mainland Industrial Output YoY (YTD) (Nov)--
F: --
P: --
China, Mainland Urban Area Unemployment Rate (Nov)--
F: --
P: --
Saudi Arabia CPI YoY (Nov)--
F: --
P: --
Euro Zone Industrial Output YoY (Oct)--
F: --
P: --
Euro Zone Industrial Output MoM (Oct)--
F: --
P: --
Canada Existing Home Sales MoM (Nov)--
F: --
P: --
Euro Zone Total Reserve Assets (Nov)--
F: --
P: --
U.K. Inflation Rate Expectations--
F: --
P: --
Canada National Economic Confidence Index--
F: --
P: --
Canada New Housing Starts (Nov)--
F: --
P: --
U.S. NY Fed Manufacturing Employment Index (Dec)--
F: --
P: --
U.S. NY Fed Manufacturing Index (Dec)--
F: --
P: --
Canada Core CPI YoY (Nov)--
F: --
P: --
Canada Manufacturing Unfilled Orders MoM (Oct)--
F: --
P: --
Canada Manufacturing New Orders MoM (Oct)--
F: --
P: --
Canada Core CPI MoM (Nov)--
F: --
P: --
Canada Manufacturing Inventory MoM (Oct)--
F: --
P: --
Canada CPI YoY (Nov)--
F: --
P: --
Canada CPI MoM (Nov)--
F: --
P: --
Canada CPI YoY (SA) (Nov)--
F: --
P: --
Canada Core CPI MoM (SA) (Nov)--
F: --
P: --


No matching data
Latest Views
Latest Views
Trending Topics
Top Columnists
Latest Update
White Label
Data API
Web Plug-ins
Affiliate Program
View All

No data
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at hospital chains stocks, starting with Acadia Healthcare .
Hospital chains operate scale-driven businesses that rely on patient volumes, efficient operations, and favorable payer contracts to drive revenue and profitability. These organizations benefit from the essential nature of their services, which ensures consistent demand, particularly as populations age and chronic diseases become more prevalent. However, profitability can be pressured by rising labor costs, regulatory requirements, and the challenges of balancing care quality with cost efficiency. Dependence on government and private insurance reimbursements also introduces financial uncertainty.Looking ahead, hospital chains stand to benefit from tailwinds such as increasing healthcare utilization driven by an aging population that generally has higher incidents of disease. AI can also be a tailwind in areas such as predictive analytics for more personalized treatment and efficiency (intake, staffing, resourcing allocation). However, the sector faces potential headwinds such as labor shortages that could push up wages as well as substantial investments needs for digital infrastructure to support telehealth and electronic health records. Regulatory scrutiny, and reimbursement cuts are also looming topics that could further strain margins.
The 4 hospital chains stocks we track reported a satisfactory Q1. As a group, revenues were in line with analysts’ consensus estimates.
Thankfully, share prices of the companies have been resilient as they are up 7% on average since the latest earnings results.
With a network of over 250 facilities serving patients in 38 states and Puerto Rico, Acadia Healthcare operates facilities providing mental health and substance use disorder treatment services across the United States.
Acadia Healthcare reported revenues of $770.5 million, flat year on year. This print was in line with analysts’ expectations, and overall, it was a strong quarter for the company with a solid beat of analysts’ sales volume estimates and an impressive beat of analysts’ EPS estimates.
Acadia Healthcare scored the highest full-year guidance raise of the whole group. Investor expectations, however, were likely higher than Wall Street’s published projections, leaving some wishing for even better results (analysts’ consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 16.8% since reporting and currently trades at $21.52.
Is now the time to buy Acadia Healthcare? Access our full analysis of the earnings results here, it’s free.
With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.
Tenet Healthcare reported revenues of $5.22 billion, down 2.7% year on year, outperforming analysts’ expectations by 1.3%. The business had a strong quarter with a solid beat of analysts’ EPS estimates and an impressive beat of analysts’ full-year EPS guidance estimates.
Tenet Healthcare scored the biggest analyst estimates beat among its peers. The market seems happy with the results as the stock is up 35.4% since reporting. It currently trades at $167.58.
Is now the time to buy Tenet Healthcare? Access our full analysis of the earnings results here, it’s free.
Weakest Q1: Universal Health Services
With a network spanning 39 states and three countries, Universal Health Services operates acute care hospitals and behavioral health facilities across the United States, United Kingdom, and Puerto Rico.
Universal Health Services reported revenues of $4.1 billion, up 6.7% year on year, falling short of analysts’ expectations by 1%. It was a mixed quarter as it posted a solid beat of analysts’ EPS estimates but same-store sales in line with analysts’ estimates.
Universal Health Services delivered the fastest revenue growth but had the weakest performance against analyst estimates in the group. As expected, the stock is down 1.1% since the results and currently trades at $171.24.
Read our full analysis of Universal Health Services’s results here.
With roots dating back to 1968 and a network spanning 20 states, HCA Healthcare operates a network of 190 hospitals and 150+ outpatient facilities providing a full range of medical services across the US and England.
HCA Healthcare reported revenues of $18.32 billion, up 5.7% year on year. This result beat analysts’ expectations by 0.5%. Aside from that, it was a mixed quarter as it also recorded an impressive beat of analysts’ EPS estimates but a slight miss of analysts’ same-store sales estimates.
HCA Healthcare had the weakest full-year guidance update among its peers. The stock is up 10.4% since reporting and currently trades at $376.86.
Read our full, actionable report on HCA Healthcare here, it’s free.
Market Update
Thanks to the Fed’s series of rate hikes in 2022 and 2023, inflation has cooled significantly from its post-pandemic highs, drawing closer to the 2% goal. This disinflation has occurred without severely impacting economic growth, suggesting the success of a soft landing. The stock market thrived in 2024, spurred by recent rate cuts (0.5% in September and 0.25% in November), and a notable surge followed Donald Trump’s presidential election win in November, propelling indices to historic highs. Nonetheless, the outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. The path forward holds both optimism and caution as new policies take shape.
NEW YORK, NY / ACCESS Newswire / June 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") . Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
Investigation Details
The investigation concerns whether Acadia Healthcare and certain of its officers and/or directors have engaged in corporate wrongdoing.
What's Next?
If you are aware of any facts relating to this investigation or purchased Acadia Healthcare shares, you can assist this investigation by visiting the firm's site: bgandg.com/ACHC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") . Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
Investigation Details
The investigation concerns whether Acadia Healthcare and certain of its officers and/or directors have engaged in corporate wrongdoing.
What's Next?
If you are aware of any facts relating to this investigation or purchased Acadia Healthcare shares, you can assist this investigation by visiting the firm's site: bgandg.com/ACHC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
Court: M.D. Tennessee
Case: 3:24-CV-01238
Lead Plaintiff has been appointed to represent investors in the class action against Acadia Healthcare.
What is this lawsuit about?
On September 1, 2024, the New York Times revealed that Acadia Healthcare detained patients without medical necessity and billed insurance providers for unnecessary treatments.
Following this, dropped by 4.5%.
Then, on September 27, 2024, shareholders filed a claim against Acadia Healthcare after the company disclosed it had received subpoenas from the U.S. Attorney’s Office and other agencies related to its admissions and billing practices. On that news, fell another 16.36%.
What can you do to recover your losses now?
We’re keeping track of all updates and will notify investors about potential recovery.
More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.
NEW YORK, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") . Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
Investigation Details
The investigation concerns whether Acadia Healthcare and certain of its officers and/or directors have engaged in corporate wrongdoing.
What's Next?
If you are aware of any facts relating to this investigation or purchased Acadia Healthcare shares, you can assist this investigation by visiting the firm's site: bgandg.com/ACHC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") . Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
Investigation Details
The investigation concerns whether Acadia Healthcare and certain of its officers and/or directors have engaged in corporate wrongdoing.
What's Next?
If you are aware of any facts relating to this investigation or purchased Acadia Healthcare shares, you can assist this investigation by visiting the firm's site: bgandg.com/ACHC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features

FastBull Membership
Not yet
Purchase
Log In
Sign Up